IP Library Granted Patent US 8,591,597
Granted Patent B2
US 8,591,597 · App. 12/728,557 · Granted Nov 26, 2013

Biomimetic vascular network and devices using the same

Inventors: David M. Hoganson (Boston, MA); Joseph P. Vacanti (Winchester, MA); Howard I. Pryor (Washington, DC)
Assignee: The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,591,597
App. No.
12/728,557
Granted
Nov 26, 2013
Kind
B2
Abstract

The invention provides method of fabricating a scaffold comprising a fluidic network, including the steps of: (a) generating an initial vascular layer for enclosing the chamber and providing fluid to the cells, the initial vascular layer having a network of channels for fluid; (b) translating the initial vascular layer into a model for fluid dynamics analysis; (c) analyzing the initial vascular layer based on desired parameters selected from the group consisting of a characteristic of a specific fluid, an input pressure, an output pressure, an overall flow rate and combinations thereof to determine sheer stress and velocity within the network of channels; (d) measuring the sheer stress and the velocity and comparing the obtained values to predetermined values; (e) determining if either of the shear stress or the velocity are greater than or less than the predetermined values, and (f) optionally modifying the initial vascular layer and repeating steps (b)-(e). The invention also provides compositions comprising a vascular layer for use in tissue lamina as well as a medical devices having a vascular layer and kits.

Claims (23)

1. An artificial vascular layer comprising:

a substrate defining a network of channels arranged in a radial pattern having at least one central output channel, a plurality of radially outward input channels, and a plurality of intermediate channels connecting the input channels and the at least one output channel, each channel having a height, a length, a width, and a diameter, wherein the intermediate channels undergo multiple branching and rejoining to form hexagonal areas intermediate to the intermediate channels,

the intermediate channels being formed by varying said height and width with respect to adjacent portions of the channels and the length of a smallest of the intermediate channels is formed based on the respective diameter whereby said smallest intermediate channel has a biomimetic length.

2. An artificial vascular layer as recited in claim 1 , wherein the channels are rectangular with an aspect ratio of 1:1.

3. An artificial vascular layer as recited in claim 1 , wherein the intermediate channels successively branch and rejoin, in a bifurcating manner, into successively smaller and larger portions, respectively, with bifurcation angles of 45 degrees.

4. An artificial vascular layer as recited in claim 1 , wherein a smallest diameter intermediate channels is preferably 200 um in diameter while a largest initial intermediate channel from the input channels are 608 um in diameter.

5. An artificial vascular layer as recited in claim 1 , wherein the biomimetic lengths of all of the channels are scaled in an equal fashion.

6. An artificial vascular layer as recited in claim 1 , wherein the intermediate channels have radii of curvature to improve the flow characteristics.

7. An artificial vascular layer as recited in claim 1 , wherein the substrate is collagen.

8. An artificial vascular layer as recited in claim 1 , further comprising elastin in the collagen substrate.

9. An artificial vascular layer as recited in claim 1 , further comprising fibronectin in the collagen substrate.

10. An artificial vascular layer as recited in claim 1 , wherein the channels carry a fluid and the fluid is blood, plasma or media.

11. An artificial vascular layer as recited in claim 1 , wherein the layer comprises a medical device for assisting or replacing an organ.

12. An artificial vascular layer as recited in claim 1 , wherein the layer comprises a tool for drug discovery, development and/or evaluation.

13. An artificial vascular layer as recited in claim 1 , wherein the layer comprises a platform for in vitro or ex vivo research and testing.

14. An artificial vascular layer as recited in claim 1 , further comprising a second header layer having a nozzle in fluid communication with the at least one output channel to connect to a vein.

15. An artificial vascular layer as recited in claim 1 , wherein the intermediate channels trifurcate at least once.

16. An artificial vascular layer comprising:

a substrate defining a network of channels arranged in a radial pattern having at least one central output channel, a plurality of radially outward input channels, and a plurality of intermediate channels connecting the input channels and the at least one output channel, each channel having a height, a length, a width, and a diameter, wherein the intermediate channels undergo multiple branching and rejoining to form hexagonal areas intermediate to the intermediate channels,

the intermediate channels being formed by varying said height and width with respect to adjacent portions of the channels and the length of a smallest diameter of the intermediate channels is formed based on the respective diameter whereby said smallest diameter channel has a biomimetic length.

17. An artificial vascular layer comprising:

a substrate defining a network of channels arranged in a radial pattern having at least one central output channel, a plurality of radially outward input channels, and a plurality of intermediate channels connecting the input channels and the at least one output channel, each channel having a height, a length, a width, and a diameter, wherein the intermediate channels undergo multiple branching and rejoining to form hexagonal areas intermediate to the intermediate channels,

the intermediate channels being formed by varying said height and width with respect to adjacent portions of the channels and the length of a smallest of the intermediate channels is formed based on the respective diameter whereby said smallest channel has a biomimetic length.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 3, 2020
From: MASSACHUSETTS GENERAL HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052819/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2010
From: PRYOR, HOWARD I.; HOGANSON, DAVID M.; VACANTI, JOSEPH P.
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 024658/0818 →
Continuity (5)
Continuation 12576826 · Oct 9, 2009
Continuation PCTUS2008004872 · Apr 14, 2008
Provisional Application 60923312 · Apr 12, 2007
Provisional Application 60923474 · Apr 12, 2007
Related Publication 20100274353A1 · Oct 28, 2010